![]() 002437 28 Jun 2019 | Other | ¥0.01 Per Share |
![]() 002437 18 Jul 2018 | Other | ¥0.01 Per Share |
![]() 002437 13 Jun 2017 | Other | ¥0.05 Per Share |
![]() 002437 3 Jun 2016 | Other | ¥0.08 Per Share |
![]() 002437 8 May 2015 | Other | ¥0.03 Per Share |
29 Oct 2024 Date | | - Cons. EPS | 0.03 EPS |
24 Aug 2024 Date | | - Cons. EPS | 0.03 EPS |
10 May 2024 Date | | - Cons. EPS | - EPS |
20 Apr 2024 Date | | - Cons. EPS | - EPS |
27 Oct 2023 Date | | - Cons. EPS | 0.09 EPS |
![]() 002437 28 Jun 2019 | Other | ¥0.01 Per Share |
![]() 002437 18 Jul 2018 | Other | ¥0.01 Per Share |
![]() 002437 13 Jun 2017 | Other | ¥0.05 Per Share |
![]() 002437 3 Jun 2016 | Other | ¥0.08 Per Share |
![]() 002437 8 May 2015 | Other | ¥0.03 Per Share |
29 Oct 2024 Date | | - Cons. EPS | 0.03 EPS |
24 Aug 2024 Date | | - Cons. EPS | 0.03 EPS |
10 May 2024 Date | | - Cons. EPS | - EPS |
20 Apr 2024 Date | | - Cons. EPS | - EPS |
27 Oct 2023 Date | | - Cons. EPS | 0.09 EPS |
Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Leifeng Guo CEO | XSHE Exchange | CNE100000QG8 ISIN |
CN Country | 2,703 Employees | - Last Dividend | 3 Jun 2016 Last Split | 23 Jun 2010 IPO Date |
Harbin Gloria Pharmaceuticals Co., Ltd is a prominent pharmaceutical company based in Harbin, People's Republic of China. Founded in the year 2000, the company dedicates itself to the research, development, production, and sale of a wide range of pharmaceutical products within the Chinese market. Harbin Gloria Pharmaceuticals has carved a niche for itself by focusing on the creation of medications that cater to various health conditions, ranging from cardiac cerebrovascular issues to antitumor treatments. The commitment to innovation and quality has positioned the company as a key player in China's pharmaceutical industry.